Transgender Researcher Was Funded by Puberty Blocker Manufacturer

Transgender Researcher Was Funded by Puberty Blocker Manufacturer

A company that sells puberty-blocking drugs funded the co-author of a study that recommends transgender medical treatments for children before puberty.

The study, titled “Sex Assigned at Birth Ratio Among Transgender and Gender Diverse Adolescents in the United States,” was authored by Jack Turban, Brett Dolotina, Dana King, and Alex Keuroghlian. 

The study was highlighted by NBC and defends what it refers to as “gender-affirming medical care” for children, which can consist of halting puberty, injecting cross-sex hormones, or amputating fully functional body parts. 

The study concludes that “The sex assigned at birth ratio of TGD adolescents in the United States does not appear to favor AFAB adolescents and should not be used to argue against the provision of gender-affirming medical care for

Trending: Ilhan Omar Voted Out Today?

Continue reading


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Thanks for sharing!
Send this to a friend